James W. Maas

8.7k total citations
139 papers, 6.6k citations indexed

About

James W. Maas is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, James W. Maas has authored 139 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Cellular and Molecular Neuroscience, 39 papers in Psychiatry and Mental health and 36 papers in Molecular Biology. Recurrent topics in James W. Maas's work include Neuroscience and Neuropharmacology Research (34 papers), Neurotransmitter Receptor Influence on Behavior (24 papers) and Treatment of Major Depression (20 papers). James W. Maas is often cited by papers focused on Neuroscience and Neuropharmacology Research (34 papers), Neurotransmitter Receptor Influence on Behavior (24 papers) and Treatment of Major Depression (20 papers). James W. Maas collaborates with scholars based in United States, Czechia and Qatar. James W. Maas's co-authors include D. Harold Landis, H. Dekirmenjian, Susan E. Hattox, D. Eugene Redmond, Yung H. Huang, Steven R. Pliszka, Alan C. Swann, James T. McCracken, Stephen H. Koslow and Charles L. Bowden and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

James W. Maas

138 papers receiving 5.7k citations

Peers

James W. Maas
David S. Janowsky United States
Joseph J. Schildkraut United States
H. Beckmann Germany
David Pickar United States
Markku Linnoila United States
Richard Jed Wyatt United States
Daniël P. van Kammen United States
Samuel Gershon United States
David S. Janowsky United States
James W. Maas
Citations per year, relative to James W. Maas James W. Maas (= 1×) peers David S. Janowsky

Countries citing papers authored by James W. Maas

Since Specialization
Citations

This map shows the geographic impact of James W. Maas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James W. Maas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James W. Maas more than expected).

Fields of papers citing papers by James W. Maas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James W. Maas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James W. Maas. The network helps show where James W. Maas may publish in the future.

Co-authorship network of co-authors of James W. Maas

This figure shows the co-authorship network connecting the top 25 collaborators of James W. Maas. A scholar is included among the top collaborators of James W. Maas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James W. Maas. James W. Maas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maas, James W., Jing Yang, & Robert H. Edwards. (2017). Endogenous Leucine-Rich Repeat Kinase 2 Slows Synaptic Vesicle Recycling in Striatal Neurons. Frontiers in Synaptic Neuroscience. 9. 5–5. 18 indexed citations
2.
Maas, James W., Lisa M. Muglia, Sherri K. Vogt, et al.. (2005). Calcium-Stimulated Adenylyl Cyclases Modulate Ethanol-Induced Neurodegeneration in the Neonatal Brain. Journal of Neuroscience. 25(9). 2376–2385. 36 indexed citations
3.
Pliszka, Steven R., James T. McCracken, & James W. Maas. (1996). Catecholamines in Attention-Deficit Hyperactivity Disorder: Current Perspectives. Journal of the American Academy of Child & Adolescent Psychiatry. 35(3). 264–272. 322 indexed citations
4.
Maas, James W., et al.. (1995). Clonidine Plus Haloperidol in the Treatment of Schizophrenia/Psychosis. Journal of Clinical Psychopharmacology. 15(5). 361–364. 14 indexed citations
5.
Katz, Martin M. & James W. Maas. (1994). Psychopharmacology and the Etiology of Psychopathologic States: Are We Looking in the Right Way?. Neuropsychopharmacology. 10(2). 139–144. 12 indexed citations
6.
Pliszka, Steven R., James W. Maas, Martin A. Javors, Graham A. Rogeness, & Jeanette Baker. (1994). Urinary Catecholamines in Attention-Deficit Hyperactivity Disorder with and without Comorbid Anxiety. Journal of the American Academy of Child & Adolescent Psychiatry. 33(8). 1165–1173. 52 indexed citations
7.
Miller, Alexander L., et al.. (1993). Acute effects of neuroleptics on unmedicated schizophrenic patients and controls. Biological Psychiatry. 34(3). 178–187. 19 indexed citations
8.
Javors, Martin A., et al.. (1993). Effects of fire ant venom alkaloids on platelet and neutrophil function. Life Sciences. 53(14). 1105–1112. 27 indexed citations
9.
Maas, James W., Salvador Contreras, Alexander L. Miller, et al.. (1993). Studies of Catecholamine Metabolism in Schizophrenia/Psychosis-I. Neuropsychopharmacology. 8(2). 97–109. 50 indexed citations
10.
Swann, Alan C., Steven K. Secunda, Stephen H. Koslow, et al.. (1991). Mania: Sympathoadrenal function and clinical state. Psychiatry Research. 37(2). 195–205. 16 indexed citations
11.
Koslow, Stephen H., James W. Maas, Alan Frazer, et al.. (1991). Identifying the specific clinical actions of amitriptyline: interrelationships of behaviour, affect and plasma levels in depression. Psychological Medicine. 21(3). 599–611. 24 indexed citations
12.
Swann, Alan C., Nancy Berman, Alan Frazer, et al.. (1990). Lithium distribution in mania: Single-dose pharmacokinetics and sympathoadrenal function. Psychiatry Research. 32(1). 71–84. 13 indexed citations
13.
Swann, Alan C., Steven K. Secunda, Jack Croughan, et al.. (1990). Stress, depression, and mania: relationship between perceived role of stressful events and clinical and biochemical characteristics. Acta Psychiatrica Scandinavica. 81(4). 389–397. 40 indexed citations
14.
Rogeness, Graham A., James W. Maas, Martin A. Javors, et al.. (1989). Attention deficit disorder symptoms and urine catecholamines. Psychiatry Research. 27(3). 241–251. 26 indexed citations
15.
Davis, John M. & James W. Maas. (1983). The Affective disorders. 61 indexed citations
16.
Maas, James W.. (1979). Biochemistry of the Affective Disorders. Hospital Practice. 14(5). 113–120. 6 indexed citations
17.
Huang, Yung H., D. Eugene Redmond, Daniel R. Snyder, & James W. Maas. (1975). In vivo location and destruction of the locus coeruleus in the stumptail macaque (Macaca arctoides). Brain Research. 100(1). 157–162. 39 indexed citations
18.
Harris, Charles L. & James W. Maas. (1974). TRANSFER RNA AND THE REGULATION OF PROTEIN SYNTHESIS IN RAT CEREBRAL CORTEX DURING NEURAL DEVELOPMENT. Journal of Neurochemistry. 22(5). 741–749. 16 indexed citations
19.
Maas, James W., et al.. (1970). A KINETIC STUDY OF THE DISPOSITION OF CIRCULATING NOREPINEPHRINE IN NORMAL MALE SUBJECTS. Journal of Pharmacology and Experimental Therapeutics. 174(3). 381–387. 23 indexed citations
20.
Maas, James W. & D. Harold Landis. (1968). IN VIVO STUDIES OF THE METABOLISM OF NOREPINEPHRINE IN THE CENTRAL NERVOUS SYSTEM. Journal of Pharmacology and Experimental Therapeutics. 163(1). 147–162. 192 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026